Kortylewski M - Search Results

1

B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors.

Zhao X, Zhang Z, Moreira D, Su YL, Won H, Adamus T, Dong Z, Liang Y, Yin HH, Swiderski P, Pillai RK, Kwak L, Forman S, Kortylewski M. Zhao X, et al. Among authors: kortylewski m. Mol Ther. 2018 Mar 7;26(3):695-707. doi: 10.1016/j.ymthe.2018.01.007. Epub 2018 Jan 17. Mol Ther. 2018. PMID: 29433938 Free PMC article.

2

Stat3 as a potential target for cancer immunotherapy.

Kortylewski M, Yu H. Kortylewski M, et al. J Immunother. 2007 Feb-Mar;30(2):131-9. doi: 10.1097/01.cji.0000211327.76266.65. J Immunother. 2007. PMID: 17471161 Review.

3

Role of Stat3 in suppressing anti-tumor immunity.

Kortylewski M, Yu H. Kortylewski M, et al. Curr Opin Immunol. 2008 Apr;20(2):228-33. doi: 10.1016/j.coi.2008.03.010. Epub 2008 May 12. Curr Opin Immunol. 2008. PMID: 18479894 Free PMC article. Review.

4

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.

Kujawski M, Kortylewski M, Lee H, Herrmann A, Kay H, Yu H. Kujawski M, et al. Among authors: kortylewski m. J Clin Invest. 2008 Oct;118(10):3367-77. doi: 10.1172/JCI35213. J Clin Invest. 2008. PMID: 18776941 Free PMC article.

5

Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment.

Kortylewski M, Xin H, Kujawski M, Lee H, Liu Y, Harris T, Drake C, Pardoll D, Yu H. Kortylewski M, et al. Cancer Cell. 2009 Feb 3;15(2):114-23. doi: 10.1016/j.ccr.2008.12.018. Cancer Cell. 2009. PMID: 19185846 Free PMC article.

6

Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice.

Zhang L, Alizadeh D, Van Handel M, Kortylewski M, Yu H, Badie B. Zhang L, et al. Among authors: kortylewski m. Glia. 2009 Oct;57(13):1458-67. doi: 10.1002/glia.20863. Glia. 2009. PMID: 19306372

7

In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses.

Kortylewski M, Swiderski P, Herrmann A, Wang L, Kowolik C, Kujawski M, Lee H, Scuto A, Liu Y, Yang C, Deng J, Soifer HS, Raubitschek A, Forman S, Rossi JJ, Pardoll DM, Jove R, Yu H. Kortylewski M, et al. Nat Biotechnol. 2009 Oct;27(10):925-32. doi: 10.1038/nbt.1564. Epub 2009 Sep 13. Nat Biotechnol. 2009. PMID: 19749770 Free PMC article.

8

STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.

Lee H, Deng J, Kujawski M, Yang C, Liu Y, Herrmann A, Kortylewski M, Horne D, Somlo G, Forman S, Jove R, Yu H. Lee H, et al. Among authors: kortylewski m. Nat Med. 2010 Dec;16(12):1421-8. doi: 10.1038/nm.2250. Epub 2010 Nov 21. Nat Med. 2010. PMID: 21102457 Free PMC article.

9

Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA.

Ma Y, Kowolik CM, Swiderski PM, Kortylewski M, Yu H, Horne DA, Jove R, Caballero OL, Simpson AJ, Lee FT, Pillay V, Scott AM. Ma Y, et al. Among authors: kortylewski m. ACS Chem Biol. 2011 Sep 16;6(9):962-70. doi: 10.1021/cb200176v. Epub 2011 Jul 26. ACS Chem Biol. 2011. PMID: 21766840 Free PMC article.

10

TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo.

Zhang Q, Hossain DM, Nechaev S, Kozlowska A, Zhang W, Liu Y, Kowolik CM, Swiderski P, Rossi JJ, Forman S, Pal S, Bhatia R, Raubitschek A, Yu H, Kortylewski M. Zhang Q, et al. Among authors: kortylewski m. Blood. 2013 Feb 21;121(8):1304-15. doi: 10.1182/blood-2012-07-442590. Epub 2013 Jan 3. Blood. 2013. PMID: 23287859 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page